NYSE:OSCR

Oscar Health, Inc. to Host 2024 Investor Day

Retrieved on: 
Wednesday, April 10, 2024
Software, Practice Management, Insurance, Managed Care, Health, Professional Services, Technology, Health Insurance, OSCR, Webcast

Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City.

Key Points: 
  • Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City.
  • Management will discuss the Company's corporate strategy, financial performance, and long-term financial targets.
  • A live webcast to the presentation and the presentation materials will be available on Oscar's investor relations website ( www.ir.hioscar.com ).
  • The webcast will be archived on Oscar’s investor relations website following June 7, 2024 for a period of 90 days.

Oscar Health, Inc. 2024 First Quarter Conference Call

Retrieved on: 
Tuesday, April 2, 2024
Health, Practice Management, Other Health, Health Insurance, Managed Care, General Health, Biotechnology, OSCR

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
  • Management will review these results in a conference call beginning at 8:00 AM (ET).
  • The call-in number and webcast link are as follows:

Thinking about buying stock in Foghorn Therapeutics, Oscar Health, Eli Lilly And Co, Palo Alto Networks, or CN ENERGY GROUP?

Retrieved on: 
Thursday, February 8, 2024
Multimedia

Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.

Key Points: 
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street.
  • We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability

Retrieved on: 
Wednesday, February 7, 2024
Professional Services, Health, Health Technology, Insurance, Health Insurance, Managed Care, MLR, Security (finance), Growth, Health care, Table, GAAP, Failure, Adjustment, Annual report, Care Act 2014, Ratio, Administration, Physician, Depreciation, Affordable Care Act, Webcast, Revenue, Total revenue, Hospital, Risk management

Medical loss ratio (MLR) is total medical expenses incurred less any member cost sharing as a percentage of premiums before ceded reinsurance.

Key Points: 
  • Medical loss ratio (MLR) is total medical expenses incurred less any member cost sharing as a percentage of premiums before ceded reinsurance.
  • The Selling, General, and Administrative (SG&A) Expense ratio is calculated as selling, general and administrative expenses as a percentage of Total Revenue.
  • We believe the SG&A Expense ratio is useful to evaluate our ability to manage our overall selling, general, and administrative cost base.
  • Oscar will host a conference call to discuss the financial results today, February 7, 2024, at 5:00 p.m. (ET).

Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

Retrieved on: 
Friday, January 26, 2024
Software, Insurance, Health, Data Management, Health Technology, Professional Services, Technology, Health Insurance, OSCR, Employment, Compensated emancipation

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar’s Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar’s common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar’s Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar’s common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates.
  • The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment.
  • The awards were granted under Oscar’s 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York Stock Exchange rules.

Oscar Health, Inc. 2023 Fourth Quarter and Full Year Earnings Conference Call

Retrieved on: 
Thursday, January 18, 2024
Professional Services, Health, Technology, Insurance, Health Insurance, Software, OSCR

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.
  • Management will review these results in a conference call beginning at 5:00 PM (ET).
  • The call-in number and webcast link are as follows:

Oscar Health, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, December 20, 2023
Technology, Insurance, Health Technology, Professional Services, Health Insurance, Software, Practice Management, Health, Data Management, Conference, OSCR

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at approximately 9:00 AM PT (12:00 PM ET) in San Francisco, CA.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at approximately 9:00 AM PT (12:00 PM ET) in San Francisco, CA.
  • All interested parties are invited to listen to a live webcast of the presentation by visiting www.ir.hioscar.com and selecting the “Events & Presentations” link.
  • Following the presentation, a webcast replay will be available on Oscar’s investor relations website for a period of 30 days.

Oscar Health, Inc. Announces that Mark Bertolini’s Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar Health

Retrieved on: 
Monday, November 20, 2023
Software, Managed Care, Health, Artificial Intelligence, Health Technology, Technology, Apps, Applications, Health Insurance, NYSE, Affordable Care Act, Care Act 2014, Privacy, Common stock, Risk-adjusted return on capital, Health care, Growth, Hospital, Physician, Failure, OSCR, Security (finance), Medicare

Deerfield will purchase an aggregate of 3,000,000 shares of Common Stock and Anahata will purchase an aggregate of 2,000,000 shares of Common Stock.

Key Points: 
  • Deerfield will purchase an aggregate of 3,000,000 shares of Common Stock and Anahata will purchase an aggregate of 2,000,000 shares of Common Stock.
  • The closing of each private placement is expected to occur on or about November 22, 2023, subject to the satisfaction of customary closing conditions.
  • Oscar is not a party to either of the Stock Purchase Agreements.
  • New factors emerge from time to time, and it is not possible for us to predict which will arise.

Oscar Health, Inc. Announces 2023 Culturally Competent Care Grant Recipients, Bolstering its Efforts to Support Rural and Hispanic and Latino Communities

Retrieved on: 
Monday, November 20, 2023
Professional Services, Public Policy, Government, Healthcare Reform, Health, Health Technology, Insurance, Health equity, NYSE, Organization, CCC, Molina Healthcare, Patient, ACA, CHW, OSCR, Transport

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants.
  • The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities.
  • With the funding, CHW anticipates serving an additional 500 individuals, and developing new Spanish literacy trainings and educational materials for the community.
  • Oscar launched the grant initiative in 2021, as a key pillar of the CCC Program, to impact change at the community level.

Oscar Health, Inc. to Present at 5th Annual Wolfe Research Healthcare Conference

Retrieved on: 
Wednesday, November 8, 2023
Software, Managed Care, Health, Artificial Intelligence, Health Technology, Technology, Apps, Applications, Health Insurance, OSCR, Conference, NYSE, Pharmaceutical industry, Broadcasting

Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 5th Annual Wolfe Research Healthcare Conference on Wednesday, November 15, 2023 at approximately 2:15 PM ET.

Key Points: 
  • Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive Officer, Mark Bertolini, is scheduled to present and provide a business update at the 5th Annual Wolfe Research Healthcare Conference on Wednesday, November 15, 2023 at approximately 2:15 PM ET.
  • All interested parties are invited to listen to a live webcast of the fireside chat by visiting www.ir.hioscar.com and selecting the “Events & Presentations” link.
  • Following each presentation, a webcast replay will be available on Oscar’s investor relations website for a period of 90 days.